Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
292 hedge funds and large institutions have $3.44B invested in Cantel Medical Corporation in 2018 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 93 increasing their positions, 100 reducing their positions, and 30 closing their positions.
77% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 30
39% more call options, than puts
Call options by funds: $8.78M | Put options by funds: $6.32M
8% more funds holding
Funds holding: 270 → 292 (+22)
7% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 100
11% less capital invested
Capital invested by funds: $3.86B → $3.44B (-$412M)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$40.6M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$32.4M |
| 3 |
Millennium Management
New York
|
+$27.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$21.5M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$20.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$91.8M |
| 2 |
BlackRock
New York
|
-$77.6M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$33.1M |
| 4 |
State Street
Boston,
Massachusetts
|
-$23.1M |
| 5 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
-$16.4M |
CMD Hedge Fund Activity: Q2 2018 in Review
292 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2018, worth a combined $3.44B — down 11% from $3.86B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new CMD positions and 30 closed out — a net gain of 23 holders — while 93 added to existing stakes and 100 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $40.6M. The largest seller was Fidelity Investments, cutting an estimated $91.8M.
- 292 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2018, up from 270 in Q1 2018.
- Funds reported $3.44B of Cantel Medical Corporation stock for Q2 2018, down 11% quarter-over-quarter.
- 53 funds opened new Cantel Medical Corporation positions in Q2 2018 and 30 closed out, a net change of +23 holders.
- The largest Cantel Medical Corporation buyer in Q2 2018 was Fred Alger Management, an estimated $40.6M added.
- The largest Cantel Medical Corporation seller in Q2 2018 was Fidelity Investments, an estimated $91.8M sold.
Based on aggregated 13F filings for Q2 2018.